Research ArticleArticle
Canadian Pain Society and Canadian Rheumatology Association Recommendations for Rational Care of Persons with Fibromyalgia. A Summary Report
Mary-Ann Fitzcharles, Peter A. Ste-Marie, Don L. Goldenberg, John X. Pereira, Susan Abbey, Manon Choinière, Gordon Ko, Dwight E. Moulin, Pantelis Panopalis, Johanne Proulx and Yoram Shir
The Journal of Rheumatology July 2013, jrheum.130127; DOI: https://doi.org/10.3899/jrheum.130127
Mary-Ann Fitzcharles
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Peter A. Ste-Marie
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Don L. Goldenberg
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
John X. Pereira
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Susan Abbey
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Manon Choinière
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Gordon Ko
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Dwight E. Moulin
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Pantelis Panopalis
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Johanne Proulx
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Yoram Shir
From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada. Based on 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome, developed by the Canadian Fibromyalgia Guidelines Committee and reviewed and endorsed by the Canadian Pain Society and the Canadian Rheumatology Association. The original guidelines are available from: http://rheum.ca/en/publications/ cra_fm_guidelines. Needs assessment for the guidelines was supported by an unrestricted educational grant from Valeant, and guideline development was supported by the Louise and Alan Edwards Foundation. M-A. Fitzcharles, MB, ChB, Division of Rheumatology, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre; P.A. Ste-Marie, BA, LLB, Alan Edwards Pain Management Unit, McGill University Health Centre, Faculty of Law, Université de Montréal; D.L. Goldenberg, MD, Division of Rheumatology, Tufts University School of Medicine; J.X. Pereira, MD, Faculty of Medicine, University of Calgary; S. Abbey, MD, Department of Psychiatry, Faculty of Medicine, University of Toronto; M. Choinière, PhD, Centre de la recherche du Centre hospitalier de l’Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal; G. Ko, MD, Division of Physiatry, University of Toronto; D.E. Moulin, MD, Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario; P. Panopalis, MD, Division of Rheumatology, McGill University; J. Proulx, Patient Representative; Y. Shir, MD, Alan Edwards Pain Management Unit, McGill University Health Centre. Address correspondence to Dr. M-A. Fitzcharles, Montreal General Hospital, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. E-mail: mary-ann.fitzcharles@muhc.mcgill.ca Accepted for publication April 19, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Canadian Pain Society and Canadian Rheumatology Association Recommendations for Rational Care of Persons with Fibromyalgia. A Summary Report
Mary-Ann Fitzcharles, Peter A. Ste-Marie, Don L. Goldenberg, John X. Pereira, Susan Abbey, Manon Choinière, Gordon Ko, Dwight E. Moulin, Pantelis Panopalis, Johanne Proulx, Yoram Shir
The Journal of Rheumatology Jul 2013, jrheum.130127; DOI: 10.3899/jrheum.130127
Canadian Pain Society and Canadian Rheumatology Association Recommendations for Rational Care of Persons with Fibromyalgia. A Summary Report
Mary-Ann Fitzcharles, Peter A. Ste-Marie, Don L. Goldenberg, John X. Pereira, Susan Abbey, Manon Choinière, Gordon Ko, Dwight E. Moulin, Pantelis Panopalis, Johanne Proulx, Yoram Shir
The Journal of Rheumatology Jul 2013, jrheum.130127; DOI: 10.3899/jrheum.130127